1903008-80-9} cov pakertinib

Cov Khoom Siv

Pom Lub Teeb daj rau Daj Hmoov
Qeeb 1.27 ± 0. 1 g \/ cm3
Cia temp. Khw ntawm -20 degree
Solubility DMOPS: 6.5 (max conc. mg \/ ml);

Daim Ntawv Thov:

Lazertinib yog ib tiam neeg thib peb ntawm EGFR Tyrosine Kinase Inhibitor (xws li cov neeg mob hauv EGFL nkaus (xws li exon 19 deletion lossis l858r kev sib hloov). Lazertinib inhibits the abnormally activated EGFR signaling pathway, blocks tumor cell growth, and has good central nervous system penetration, which can alleviate brain metastases.
 

Cov lus txhais lus:

Qoginib

1903008-80-9

Yh -25448

Gns -1480

2-} propົວ, N - ({5- (({}} ({}}}} h-pyrazol {{8} } yl) {-2- Pyrimidinyl) -4- metoxy}} morpholinyl) -

N - ({5- (({} ({}}} h-pyazol {{}} yl) -2- Pyrimidinyl) {{9} Methoxy}}} morpholinyl) Acrylamide

Cim npe nrov: {{{0 {0}} ikertinib, Tuam Tshoj {1903008-80-9 cov neeg tsim khoom, cov chaw muag khoom